達(dá)比加群膠囊
所屬分類(lèi)
國(guó)際原料藥
Dabigatran Etexilate Capsules
產(chǎn)品詳情
Dabigatran Etexilate Capsules
Indication:
Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation
Treatment and Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism
Original company: Boehringer Ingelheim
Original brand: Pradaxa
上一頁(yè)